Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Ip Group (IPO) Regulatory News

Date Source Headline
28th May 2021 10:00 am RNS Joint venture with China Everbright to launch fund
27th May 2021 7:00 am RNS Portfolio co Pulmocide completes $92m Series C
26th May 2021 2:44 pm RNS Update on AGM
20th May 2021 10:01 am RNS Scrip Dividend Reference Price
17th May 2021 12:44 pm RNS Additional fair value gain of £20m
12th May 2021 12:08 pm RNS Holding(s) in Company
10th May 2021 11:15 am RNS Investor webinars
6th May 2021 6:13 pm RNS Notice of AGM, Annual Report, Scrip Dividend
6th May 2021 5:55 pm RNS LTIP & DBSP awards; Director/PDMR shareholding
5th May 2021 7:00 am RNS Portfolio company Kuur acquired by Athenex
5th May 2021 7:00 am RNS Portfolio company Inivata acquired by NeoGenomics
4th May 2021 7:00 am RNS Portfolio company Oxford Nanopore raises £195m
7th Apr 2021 11:27 am RNS Director/PDMR Shareholding
31st Mar 2021 9:15 am RNS Holding(s) in Company
30th Mar 2021 7:05 am RNS Oxford Nanopore announces preparing for IPO in H2
26th Mar 2021 12:26 pm RNS EMA positive opinion for Diurnal's Chronocort
10th Mar 2021 7:00 am RNS Annual Results
4th Mar 2021 6:07 pm RNS Holding(s) in Company
2nd Mar 2021 12:03 pm RNS Holding(s) in Company
24th Feb 2021 10:33 am RNS Notice of Results
18th Feb 2021 4:31 pm RNS Holding(s) in Company
18th Feb 2021 8:00 am RNS Holding(s) in Company
17th Feb 2021 7:00 am RNS Portfolio company ApcinteX acquired by Centessa
10th Feb 2021 7:00 am RNS IP Group, Inc. raises $50.0m (£36.5m*) of funding
9th Feb 2021 3:52 pm RNS Holding(s) in Company
2nd Feb 2021 5:15 pm RNS Holding(s) in Company
11th Jan 2021 5:29 pm RNS Holding(s) in Company
6th Jan 2021 4:57 pm RNS Portfolio co Hinge Health completes $300m round
6th Jan 2021 11:34 am RNS Holding(s) in Company
6th Jan 2021 7:00 am RNS Portfolio co Oxbotica completes £36m funding round
4th Dec 2020 11:41 am RNS Holding(s) in Company
3rd Dec 2020 8:01 am RNS Artios and Merck in global strategic collaboration
25th Nov 2020 7:00 am RNS Director Declaration
23rd Nov 2020 5:05 pm RNS Holding(s) in Company
21st Oct 2020 7:00 am RNS Investor webinar
13th Oct 2020 7:00 am RNS Oxford Nanopore funding round and contract win
9th Oct 2020 9:46 am RNS Oxford Nanopore's LamPORE test gains CE-IVD mark
7th Oct 2020 7:00 am RNS Enterprise Therapeutics' program acquired by Roche
23rd Sep 2020 1:40 pm RNS Holding(s) in Company
15th Sep 2020 12:07 pm RNS Second Price Monitoring Extn
FTSE 100 Latest
Value8,809.74
Change53.53